Section 1: Primary Injury and the Secondary Cascade

~2:02 – Primary Injury and the Secondary Cascade

Bottom line: five primary injury mechanisms (compression, contusion, distraction, laceration, shear) with compression the most common mechanism and contusion the most common pathologic finding; true anatomic transection is rare even in clinically complete injuries; secondary injury extends damage over hours to weeks via vascular failure, glutamate excitotoxicity with calcium influx, free-radical lipid peroxidation, neutrophil and macrophage infiltration, oligodendrocyte apoptosis, and glial scar formation.

Primary injury is the immediate mechanical damage that occurs at the moment of impact. It is irreversible and initiates everything downstream. Five principal mechanisms are testable. Compression is the most common mechanism: bone fragments, disc material, or ligamentous structures are displaced into the canal and compress the cord. Compression may be transient (hyperextension pinches the cord between hypertrophied ligamentum flavum and osteophytic ridges) or sustained (a burst fracture with retropulsed bone occupying the canal). Contusion is the most common pathologic finding. The cord sustains a bruise-type injury producing central hemorrhagic necrosis of the gray matter, which has higher metabolic demand and richer vascular supply than white matter. Peripheral white matter is relatively preserved in less severe injuries. Compression is the mechanism; contusion is the finding.

Distraction is longitudinal stretching of the cord beyond its elastic tolerance, characteristic of flexion-distraction (Chance) fractures and possible without fracture in children, patients with Down syndrome, or patients with rheumatoid arthritis. Distraction may also damage perfusing vessels and produce ischemia. Laceration and transection involve direct tearing by penetrating objects (knives, bullets, bone fragments). Complete anatomic transection is rare even in clinically complete injuries; most clinically complete injuries represent severe contusion with hemorrhagic necrosis. The persistent intact though dysfunctional tissue is the substrate for neuroprotective interventions. Shear involves rotational or translational forces that tear neural tissue at the gray-white matter interface, commonly accompanying fracture-dislocations.

Secondary injury is the progressive cascade of cellular, molecular, and biochemical events that extend neural damage beyond the initial mechanical insult. It begins within minutes and may continue for months. The cascade is the primary therapeutic target for neuroprotective interventions, and its timeline is heavily tested.

The vascular phase comes first. Mechanical disruption of intramedullary vasculature produces petechial hemorrhages in the central gray matter within minutes; over the first 4–8 hours these coalesce into hemorrhagic necrosis. Traumatic vasospasm of the anterior spinal artery and sulcal arteries combined with microvascular thrombosis produces ischemia in watershed zones. Critically, the injured cord segment loses its autoregulation: normal cord vasculature can maintain constant perfusion across a range of systemic blood pressures, but after injury perfusion becomes passively dependent on systemic mean arterial pressure (MAP). This is the rationale for the MAP target of 85–90 mmHg for 5–7 days post-injury. Reperfusion injury layers on top: when blood flow returns to ischemic tissue, reintroduced oxygen generates reactive oxygen species (ROS) that paradoxically worsen damage.

The biochemical phase is dominated by excitotoxicity. Mechanical disruption and ischemia release massive glutamate from damaged neurons and glia, with extracellular glutamate elevated within the first 3 hours and a possible second wave at 2–3 days. Excessive glutamate activates NMDA, AMPA, and kainate receptors, all of which produce uncontrolled calcium influx. Intracellular calcium overload activates calpains (proteases that degrade cytoskeletal proteins), phospholipases (which break down cell membranes), and nitric oxide synthase. It causes mitochondrial dysfunction and uncoupling of oxidative phosphorylation. Free radicals including superoxide anion, hydroxyl radical, and hydrogen peroxide overwhelm endogenous antioxidant defenses (superoxide dismutase, catalase, glutathione peroxidase), causing lipid peroxidation of cell membranes, protein oxidation, and DNA damage. The arachidonic acid cascade compounds the damage: phospholipase A2 releases arachidonic acid, cyclooxygenase produces prostaglandins and thromboxanes, and lipoxygenase produces leukotrienes, all of which generate additional free radicals and inflammatory mediators.

The inflammatory phase is double-edged. Within minutes to hours, resident microglia activate and secrete pro-inflammatory cytokines (tumor necrosis factor alpha [TNF-α], interleukin-1 beta [IL-1β], interleukin-6 [IL-6]). Neutrophil infiltration begins at 6–12 hours and peaks at 24–48 hours, releasing proteases, ROS, and myeloperoxidase that damage surrounding tissue. Macrophage infiltration begins at 3–5 days and peaks at 5–7 days. The pro-inflammatory M1 macrophage phenotype dominates initially, then transitions over 7–14 days toward the anti-inflammatory M2 phenotype (secreting interleukin-10 [IL-10], transforming growth factor beta [TGF-β], and neurotrophic factors). Over weeks to months, reactive astrocytes form the glial scar and deposit chondroitin sulfate proteoglycans (CSPGs) that create both a physical and chemical barrier to axonal regeneration. The glial scar is dual-edged: it seals the lesion and prevents inflammatory expansion, but the dense astrocyte mesh and CSPGs are major regenerative barriers (the target of investigational therapies like chondroitinase ABC).

The apoptotic phase peaks at 7–14 days and is particularly devastating for oligodendrocytes, the myelinating cells of the central nervous system. Loss of oligodendrocytes produces secondary demyelination of axons that survived the initial injury, contributing to functional deficits disproportionate to primary axonal damage. Both intrinsic (cytochrome c, caspase-9) and extrinsic (Fas ligand, caspase-8) pathways are activated; the final common pathway converges on caspase-3, the executioner caspase.